Johnson & Johnson is investing $2 billion to expand a North Carolina manufacturing facility as part of a broader initiative toward onshore biopharmaceutical manufacturing and expand the pipeline of available medicines in the U.S.

The company will spend the money over a 10-year period to operate a 160,000-square-foot dedicated manufacturing facility at Fujifilm's new biopharmaceutical manufacturing site in Holly Springs to expand its U.S. manufacturing capacity and boost jobs. The added investment will help create approximately 120 new jobs in North Carolina.

The company aims to share plans for additional advanced manufacturing facilities in the U.S. as well as the expansion of current U.S. sites in the coming months, further highlighting the investments it is making to ensure the vast

See Full Page